Heparanase, galectin-3, and tissue factor mRNA are expressed in benign neoplasms of the thyroid

Endocrine. 2003 Nov;22(2):81-4. doi: 10.1385/ENDO:22:2:81.

Abstract

Objective: Heparanase, galectin-3, and tissue factor (TF) are overexpressed in solid malignant thyroid tumors. We studied their expression in multinodular goiters (MNGs).

Design and methods: Thyroid tissue specimens from 15 MNGs were obtained during surgery. mRNA expression for galectin-3, heparanase, and TF was assessed by RT-PCR.

Results: Isolated expressions of heparanase and galectin- 3 mRNA were expressed in 2 and 4 of the 15 MNGs, respectively; 8/15 MNGs were positive for both heparanase and galectin-3. TF mRNA was found in all MNG specimens.

Conclusion: Galectin-3, heparanase, and TF RNA expression is prevalent in MNGs. Further studies will be needed to determine the prognostic significance of these findings.

MeSH terms

  • Biomarkers, Tumor / analysis*
  • Female
  • Galectin 3 / analysis*
  • Galectin 3 / genetics
  • Glucuronidase / analysis*
  • Glucuronidase / genetics
  • Goiter, Nodular / metabolism*
  • Humans
  • Male
  • RNA, Messenger / analysis
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thromboplastin / analysis*
  • Thromboplastin / genetics
  • Thyroid Neoplasms / chemistry

Substances

  • Biomarkers, Tumor
  • Galectin 3
  • RNA, Messenger
  • Thromboplastin
  • heparanase
  • Glucuronidase